May 2, 2024

Figure S3 from Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts

View Full Paper

Ask AI

Bookmark

Abstract

Total ion chromatograms (TICs) of the sample metabolites of Cohort 1 and Cohort 2 detected by UHPLC under negative (A, C) and positive (B, D) ion modes.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Xu et al. (2024) studied this question.

synapsesocial.com/papers/68e6be8ab6db64358763e1e3 https://doi.org/10.1158/1535-7163.25735626

View Full Paper

Ask AI

Bookmark

Abstract

Total ion chromatograms (TICs) of the sample metabolites of Cohort 1 and Cohort 2 detected by UHPLC under negative (A, C) and positive (B, D) ion modes.

Figure S3 from Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts

Abstract

Discussion

Cite This Study

Figure S3 from Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts

Abstract

Discussion

Cite This Study

Keep reading

Keep reading